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The Toll-like receptor (TLR) family functions to recognize conserved microbial and viral structures with the purpose of activating signal
pathways to instigate immune responses against infections by these organisms. For example, in vitro studies reveal that the TLR3 ligand is a
double-stranded RNA (dsRNA), a product of viral infections. From this observation, it has been proposed that TLR3 is likely an important first
signal for virus infections. We approached this issue by investigating the role of TLR3 in four different infectious viral models (lymphocytic
choriomeningitis virus (LCMV), vesicular stomatitis virus (VSV), murine cytomegalovirus (MCMV), and reovirus) and in TLR3 genetically
deficient (/) mice. Our results indicate that TLR3 is not universally required for the generation of effective antiviral responses because the
absence of TLR3 does not alter either viral pathogenesis or impair host’s generation of adaptive antiviral responses to these viruses.
D 2004 Elsevier Inc. All rights reserved.Keywords: Toll-like receptor 3; Virus; MiceIntroduction
Ten distinct mammalian Toll-like receptors (TLRs) have
been described, most of which have been shown to function
as receptors for pathogen-associated molecular patterns
(Akira and Hemmi, 2003; Takeda et al., 2003). These
receptors aid the host to combat infection as microbial
ligands upon binding to various TLRs on antigen-presenting
cells (APCs) trigger NF-nB leading to the upregulation of
cytokines and co-stimulatory molecules with the presumed
purpose of initially enhancing innate immune attack against
the pathogen from which that ligand is derived (Aderem and
Ulevitch, 2000; Anderson, 2000; Hallman et al., 2001; Kopp
and Medzhitov, 1999). It has been hypothesized that loss of
function of particular TLRs causes the host to become more
susceptible to infections with TLR-reactive pathogens. Ev-
idence supporting this concept comes from observations0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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bility to Staphylococcus aureus infections (Takeuchi et al.,
2000), loss of TLR9 resulted in ablation of the immuno-
stimulatory properties of bacterial DNA (Hemmi et al.,
2000), and loss of TL4 resulted in increased susceptibility
to respiratory syncytial virus (Kurt-Jones et al., 2000). These
results led to the proposal that TLR3, a receptor demonstrat-
ed to be reactive to double-stranded (ds) RNA (Alexopoulou
et al., 2001; Matsumoto et al., 2002), a frequent byproduct of
virus replication, functions as a universal virus receptor for
priming the innate immune system to viral infections.
Of the TLRs studied, only TLR3 has been identified to
respond to dsRNA (Alexopoulou et al., 2001) by specifically
recognizing poly (I:C) and purified Lang reovirus genomic
dsRNA, both of which resulted in the induction of IFN-h,
IL-12, IL-6, and TNFa from macrophages obtained from
TLR3-sufficient mice. The ability of TLR3 to induce IFN-h
has been attributed to at least two factors: its MyD88-
independent activation of IRF3 and to its induction of the
traditional dsRNA-dependent protein kinase (PKR) pathway
(Doyle et al., 2002; Horng et al., 2001; Oshiumi et al., 2003).
Recognition of dsRNA ligand has been demonstrated to
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vented TLR3-mediated responses to poly (I:C) in vitro
(Matsumoto et al., 2002). In vivo studies using TLR3-
deficient (/) mice showed protection of such mice from
shock induced by poly (I:C) treatment, suggesting this
receptor contributed to the in vivo recognition of and
responses to extracellular dsRNA (Alexopoulou et al.,
2001). Furthermore, it was shown that the effector responses
elicited by TLR3–poly (I:C) interaction can inhibit murine g
herpesvirus 68 replication in bone marrow-derived macro-
phage cultures (Doyle et al., 2002). Based on the above
findings, it has been repeatedly assumed that TLR3 likely
played an important role in host defense against virus
infections (Akira and Hemmi, 2003; Alexopoulou et al.,
2001; Doyle et al., 2002; Harte et al., 2003; Matsumoto et al.,
2002; Renshaw et al., 2002). However, it has not yet been
determined if the physiologic amounts of dsRNA naturally
made during viral infections per se were sufficient to trigger
through TLR3 a biologically meaningful response to alter the
outcome of disease. We set out to experimentally determine
if TLR3 is essential for antiviral immunity or if TLR3
represents an expendable level of redundancy built into the
dsRNA recognition system. Here we report our work that
directly tests this hypothesis by studying both host immune
responses and control of infection by a dsRNA virus,
reovirus; two ssRNA viruses that make dsRNA intermedi-
ates, lymphocytic choriomeningitis virus (LCMV) and ve-
sicular stomatitis virus (VSV); and a DNA virus, murine
cytomegalovirus (MCMV), in TLR3 gene-disrupted mice.
Our results indicate that TLR3 does not play a critical role in
the host antiviral adaptive immune response to reovirus,
LCMV, VSV, or MCMV as susceptibility to infection and
generation of CD4 and CD8 T cell immune responses to
these viruses are equivalent in TLR3-deficient and -sufficient
mice.Results and discussion
Our initial experiments studied the primary adaptive im-
mune responses to LCMV infection in TLR3/ mice.
LCMV is an arenavirus containing a genome consisting of
two negative-stranded RNAs and like the other viruses
investigated in this report is able to trigger Type-I IFNs.
Control of acute LCMVinfection is totally mediated by virus-
specific CD8+ T cells through a perforin-mediated pathway
(Anderson et al., 1985; Kagi et al., 1995). To test if TLR3
plays a role in the immune response to LCMV, TLR3/mice
and control C57Bl/6 (B6)  129 mixed background mice
bred at TSRI vivarium were inoculated intraperitoneally with
1  105 pfu LCMVARM53b. IFNg responses from LCMV-
specific T cells were assessed 8 days postinfection via
intracellular cytokine staining and flow cytometry following
a 5-h culture of splenocytes with brefeldin A, rIL2, and CD8
and CD4 LCMV-specific H-2b-specific peptide epitopes,
GP61 (aa GP61–80) and GP33 (aa GP33–41), respectively(Hudrisier et al., 1997; Murali-Krishna et al., 1998; Whitmire
et al., 1998). TLR3/ mice showed no difference compared
to controls in their ability to generate both a robust CD8+ and
CD4+ IFNg response to LCMV (Fig. 1A). Furthermore,
LCMV-specific CD8+ T cells from TLR3/ mice also
displayed normal lysis of GP33 peptide-coated H-2b-MC57
targets cells (Fig. 1B).
Hosts usually encounter pathogens during natural infec-
tions at significantly lower concentrations than utilized in
many laboratory infectious models. To investigate a role for
TLR3 during a low-level infection, we conducted experi-
ments in which both the dose and route of inoculation of
LCMV were varied. A series of ip and foot pad inoculations
with doses of LCMV ranging from as little as 1  102 to 5 
105 pfu LCMV were carried out and CD8+ T cell IFNg
responses from both the draining lymph nodes and spleen
were analyzed (Fig. 1C). Intravenous injection of a very high
dose of LCMV (2  106 pfu) was also analyzed (data not
shown); however, irrespective of the route and dose of virus
inoculation, the absence of TLR3 did not affect the generation
of the primary cellular response to LCMV.
We next assayed the primary T cell responses to a RNA
virus, VSV, and a DNA virus, MCMV, in TLR3/ mice.
VSV, a member of the Rhabdovirus family, contains a single-
stranded negative-sense RNA genome, and control of VSV in
mice is dependent on the generation of virus-specific anti-
bodies and complement (Lefrancois, 1984; Steinhoff et al.,
1995). Furthermore, VSV infection leads to induction of
Type-I IFNs triggered, in part, by the prevalence of structured
dsRNA-defective interfering particles found during VSV
infection (Holland, 1987). We found that TLR3/ mice
handle VSV infection as well as B6  129 control mice.
Mice infected with VSV generated both CD4+ and CD8+
VSV-specific T cell responses to peptides NP415 and NP52,
respectively (Fig. 2A), and were able to clear the virus (data
not shown). MCMV is a dsDNA herpes virus that, like
LCMV, is a natural pathogen of mice. MCMV infection of
susceptible strains of mice results in lifelong latent infection
punctuated by spontaneous reactivation from the latent state.
Protection of the host from lethal MCMV infection is com-
plex requiring contributions from both the innate and adap-
tive immune response (Koszinowski et al., 1990). The effect
of the loss of TLR3 on the T cell response to MCMV in
TLR3/mice was analyzed day 9 postinfection with 1104
pfu ip. T cell IFNg responses were measured after 5-h culture
in aCD3-coated wells because there are no currently defined
H-2b T cell peptide epitopes for MCMV. These analyses did
not identify differences between control and TLR3/ mice
in the primary T cell response to MCMV (Fig. 2B). Further-
more, the spleens from these mice were free of virus,
indicating that the absence of TLR3 did not increase the
susceptibility to MCMV (data not shown).
Next we determined the role TLR3 played in functional
T cell memory responses. Intravenous inoculation of naive
or immunosuppressed mice with LCMV variant Cl 13 (2 
106 pfu) leads to establishment of persistent infection
Fig. 1. Absence of TLR3 does not affect primary CD4+ or CD8+ T cell responses to LCMV. TLR3/ mice and control mice (n = 3 mice per group) were
infected with LCMVARM53b (1  105 pfu ip), infection with TLR3/ and control splenocytes was obtained 8 days later. (A) Cells were stimulated in vitro
with either LCMV-specific CD4+ or CD8+ T cell peptide epitopes in the presence of brefeldin A. IFNg responses were measured by intracellular cytokine
staining in combination with CD8+ and CD4+ surface staining. Results are represented as percentage of IFNg-positive cells within respective CD4+ or CD8+
populations. (B) Measurement of CD8+ T cell lytic function was assessed via standard chromium release assay against GP33 peptide-coated syngeneic and
allogeneic cells; MC57 and BALB17 cells respectively. (C) TLR3/ mice respond efficiently to LCMV irrespective of route and dose of inoculation. TLR3/
and control mice (n = 3–4 mice per group per condition) were inoculated with LCMVARM 53b using either foot pad or ip injection and varying doses as
indicted. IFNg responses from GP-33-specific T cells were analyzed 8 days postinfection from draining lymph nodes in foot pad-injected mice and splenocytes
from ip-injected mice. Results are represented as percent IFNg+ CD8+ T cells of total CD8+ T cell population. Data represented in A and B are derived from
individual experiments while those for C are compiled from several experiments.
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nized with LCMV ARM53b develop T cell memory
responses that are able to prevent establishment of persistent
infection by subsequent LCVM Cl 13 challenge (Arbour et
al., 2002). TLR3/ mice were tested for the ability to
generate a lasting functional memory response to LCMV
infection. LCMV immune TLR3/ and control mice (1 
105 pfu LCMVARM53b ip) were inoculated 3 months after
primary challenge with 2  106 pfu LCMV Cl 13 via iv
injection. The CD4+ and CD8+ T cell responses of these
mice were analyzed 3 days after inoculation. All mice
showed levels of IFN-g+ LCMV-specific T cells that were
not statistically different, indicating normal induction of the
T cell memory response (Fig. 2C).The last series of studies employed a double-stranded
RNA virus infection of neonatal TLR3/ and control mice
using Type 3 reovirus strain Dearing (T3D). Intracerebral
inoculation of neonatal mice is the classic experimental
model for evaluating virulence of neurotropic viruses such
as reovirus. We therefore compared mortality, viral titer, an-
tigen distribution, and neuropathology in newborn TLR3/
and control TLR3+/+ injected intracerebrally with T3D. There
was no difference between T3D-infected TLR3+/+ control
mice and T3D-infected TLR3/mice in virus-induced CNS
injury. The localization and the severity of viral CNS pathol-
ogy were similar in both strains of mice, with the brunt of
virus-induced injury present in the CA2–3 region of the
hippocampus, cingulate gyrus, fronto-parietal cortex, and
Fig. 2. (A–B) Primary T cell responses to VSV and MCMVare normal in TLR3/ mice. Splenocytes were isolated from TLR3/ and control mice 8 days
postinfection with VSV (2 106 pfu iv) or 9 days postinfection with MCMV (1 104 pfu ip). Cells from VSV-infected mice were stimulated for 5 h with either
CD8-specific peptide epitope NP52 or CD4-specific peptide epitope NP415, while cells from MCMV-infected mice were stimulated with a-CD3. Groups
consisted of 3–4 mice. All data represent averages of results from individual mice derived from three experiments and are represented as percent IFNg+ T cells of
respective CD8+ or CD4+ T cell populations. (C) TLR3/ mice have functional T cell memory responses. TLR3/ and control mice (n = 2 per group) were
immunized with LCMVArm 53b (1  105 pfu ip). These mice were challenged with LCMV Cl 13 (2  106 pfu iv) 3 months after immunization. Splenocytes
were isolated 3 days post-secondary challenge, and responses to CD4 peptide epitope GP61 and CD8 peptide epitopes GP33 and NP396 were measured. Results
are presented as percent IFNg+ cells of either CD4+ or CD8+ cell populations.
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haus et al., 1997; Raine and Fields, 1973; Richardson-Burns
et al., 2002). CNS injury is evidenced by the presence of
numerous pyknotic and apoptotic cells, some infiltrating
inflammatory cells, disruption of cytoarchitecture, and loss
of tissue integrity (see Fig. 3). The viral antigen co-localized
with areas of CNS injury with anti-T3D immunohistochem-
ical staining present in the hippocampus, cortex, and thala-
mus. Fig. 4 shows viral antigen staining in the dorsal
thalamus and CA3 region of the hippocampus from T3D-
infected TLR3+/+ and TLR3/ mice (Fig. 4). There was no
difference in survival between T3D-infected TLR3+/+ and
control mice. Mortality was 40% by day 7 in TLR3/mice,
with all six survivors appearing moribund. Mortality was
37.5% in control TLR3+/+ mice, with all five survivors
appearingmoribund.Mean weight of mice on day of sacrifice
(d7) was 3.53 g for TLR3/ mice and 3.90 g for TLR3+/+
control mice. Viral titer in the brain at time of sacrifice was the
same in the two groups of mice (8.94 F 0.06 log10 pfu/ml in
TLR3/ mice compared to 9.00 F 0.13 in control TLR+/+
mice).In summary, our data indicate that the TLR3 signaling
pathway does not appear to influence the generation of
effective antiviral responses for a range of virus infections,
thereby calling into question whether it represents a uni-
versal element in antiviral immunity. Although we did not
observe enhanced susceptibility with our strain and dose of
MCMV, others (Hoebe et al., 2003) using mice deficient in
lps2, a downstream component of the TLR3 signaling
pathway, noted increased susceptibility to MCMV at higher
doses of virus. So it appears that there may be some
conditions where TLR3 does enhance immunity, and that
it may be restricted to the early control of an overwhelming
viral infection requiring a fast and strong IFN type-I innate
response to prevent host death. One question that arises
from the current studies is whether TLR3 can in fact
recognize any component of these viruses. Using an in
vitro assay where the various TLR genes are transfected and
expressed in HeLa and HEK cells, UV-inactivated LCMV
Arm 53b and other arenaviruses were unable to activate
cells expressing TLR3 while control poly I:C did, again
indicating that TLR3 is unlikely to play a role in the
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arenaviruses did activate other TLR receptors (de Silva
and Kunz, unpublished observations). It is also possible
that TLR3 is not capable of recognizing the viral RNA
intermediates of LCMV, VSV, and MCMV. This is not true
for reovirus where Alexopoulou et al. (2001) identified
TLR3 recognition of purified reovirus genomic dsRNA.
Hence, it is possible that during these viral infections, TLR3Fig. 4. There is no difference between TLR3-deficient mice and wild-type
control mice in T3 reovirus-induced injury in the CNS. (A) Immunohisto-
chemistry (IHC) for T3 reovirus antigen shows numerous T3D-positive cells
(dark brown) in brains of T3D-infected TLR3+/+ wild-type control mice.
Antigen staining is evident in the same brain regions in which T3 reovirus
injury is present (compare to Fig. 3). (B) IHC for T3 reovirus antigen in brain
of T3D-infected TLR3/mouse shows similar antigen levels to that seen in
the T3D-infected TLR3+/+ wild-type control mouse brains.
Fig. 3. There is no difference between TLR3-deficient mice and wild-type
mice in T3 reovirus-induced injury or T3 reovirus antigen expression in the
CNS. (A) Uninfected control mouse brain stained with hematoxylin and
eosin (H&E) shows normal CNS cytoarchitecture and normal appearing
nuclei of viable cells. (B) H&E-stained brain from T3D-infected TLR3+/+
wild-type mouse shows characteristic T3 reovirus-associated injury
throughout the brain evidenced by cell death, loss of normal cytoarchitecture,
and loss of tissue integrity in the cingulate gyrus (CG), fronto-parietal cortex
(FPC), hippocampus (HC), and thalamus (THA). (C) H&E-stained brain
from T3D-infected TLR3-deficient (TLR3/) mouse shows T3 reovirus-
induced CNS injury comparable to that seen in T3D-infected TLR+/+ wild-
typemice. * = brain region with viral injury, cell loss, apoptotic cells, and loss
of cytoarchitecture; arrow = brain region with cell loss.never comes in contact with unsequestered or exposed viral
RNAs. Alternatively and a more likely scenario is that the
concentrations of dsRNA made during natural infection are
not sufficient to bind to and significantly influence TLR3
signaling when compared to the high concentrations used
for in vitro studies.Materials and methods
Mice
TLR3/ mice on C57BL/6  B129 mixed background
and matched control mice were derived at Yale University
and bred at The Scripps Research Institute. Mice were bred
and maintained under specific pathogen-free conditions.
Virus strains
Stocks of both LCMVARM 53b and variant LCMVCl 13
were grown up via single passage in baby hamster kidney
(BHK) cells from stocks that had been previously triple
plaque purified in Vero cells (Ahmed et al., 1984; Dutko and
Oldstone, 1983). VSV stocks were generated by collection of
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(Lyles et al., 1992). Stocks of the Smith strain of MCMVof
virus derived from in vivo propagation in salivary glands of
Balb/c mice were obtained from Dr. Raymond Welsh at the
University of Massachusetts Medical School, Worcester,
MA (Bukowski et al., 1984). Reovirus strain type 3 Dearing
(T3D) was identified, passaged, and quantitated as previous-
ly reported (Tyler et al., 1985, 1989).
LCMV, VSV, and MCMV methods
LCMV ARM 53b was inoculated into mice intraperito-
neally with either 5  103, 1  105, or 5  105 pfu where
noted. Footpad injection experiments with LCMVARM 53b
were conducted with 1  102 or 5  102 pfu virus.
Secondary challenges with LCMV Cl 13 were performed
intravenously with a dose of virus previously demonstrated
to result in persistent infection in naive mice (2 106 pfu). In
experiments using VSV, the virus was injected intravenously
at a dose of 2  106 pfu. Mice infected with MCMV were
inoculated intraperitoneally with 1  104 pfu virus.
Reovirus methods
Two-day-old neonatal mice (weight: 1.5–2 g) were used
in reovirus T3D studies. Eight control (C57BL/6  129) and
10 TLR3/ mice on the same background were infected
with 107 pfu of T3D intracerebrally in a 10-Al volume using a
29-gauge needle connected to a Hamilton microsyringe.
Animals were sacrificed for tissue collection at day 7
postinfection, by which time all animals were moribund.
Tissue was collected for histology, immunocytochemistry,
and determination of viral titer by plaque assay. T3D infected
and 5 were not virally infected (uninfected control). Nine
TLR3/ mice were T3D infected. Mice were inoculated
with T3D (1  105 PFU) via intracerebral or intracranial (ic)
injection with each mouse pup weighing about 1.7 g.
Injections were made using a 29-gauge needle in a 10-
Al volume. Animals were sacrificed by decapitation 7 days
after infection.
Analysis of T cell responses
All data represent averages of results from individual
mice with 3–5 per group. Splenocytes from LCMV- or VSV-
infected mice were cultured for 5 h in RPMI 7% FCS with 50
U/ml rIL2 and 1 Ag/ml MHC class-I or class-II restricted
peptides. T cells from MCMV mice were cultured for 5 h in
a-CD3-coated wells in RPMI 7% FCS + 50 U/ml rIL2.
Brefeldin A (1 Ag/ml) was added to all cultures at least 3
h before staining. Surface and intracellular staining proce-
dures were performed as previously described using CD4-
FITC, CD8-PE, and IFNg-APC antibodies (Homann et al.,
1998). Antibodies used in these experiments were obtained
from Pharmingen. CD8+ T cell cytolytic function was
measured by standard 5 h 51Cr release assay using MC57and BALB17 mouse fibroblasts coated with LCMV peptide
GP33–41 (1-h incubation with 1 Ag/ml peptide followed by
three washes).
MHC H-2b restricted peptides
Peptides were obtained from PeptidoGenic Research.
Peptides used were LCMV MHC Class-I: GP33–41,
NP396–404; LCMV MHC Class-II: GP61–80; VSV
MHC Class-I: NP52–59; VSV MHC Class-II GP 415–433.
Histology
For histopathologic and immunohistochemical staining,
five or six whole mouse brains per treatment group were
fixed by immersion in 10% buffered formalin for 24–30 h at
room temperature (RT), then cut in half along the mid-
coronal line for sectioning. Fixed tissues were transferred
to 70% ethanol, paraffin embedded, and sectioned at 4-Am
thickness. For each animal, two coronal sections were
stained with hematoxylin and eosin (H&E) for studies of
the extent of virus-induced pathology. Paraffin-embedded
sections were baked at 57 jC for 5 min to enhance antigen
retrieval, then de-paraffinized by immersion in mixed
xylenes followed by rehydration in a series of descending
ethanol concentrations followed by PBS.
Immunohistochemistry
Brain tissue sections were de-paraffinized by baking for
5 min at 57 jC, immersion in mixed xylenes, then rehy-
dration in graded alcohols. For viral antigen staining, de-
paraffinized tissues were permeabilized in PBS/0.1% Triton
X (PBSX) for 1 h at room temperature (RT), then non-
specific binding was blocked in 3% BSA/PBS for 1 h at RT.
Tissue was incubated with primary antibody anti-T3D
polyclonal (laboratory stock) diluted (1:200) in 3% BSA/
PBSX for 1 h at 37 jC, then washed in PBSX. Secondary
antibody anti-rabbit-Alexafluor594 (Molecular Probes,
Eugene OR) diluted 1:100 in 1.5% BSA/PBSX was incu-
bated with tissue for 1 h at RT in the dark. Tissues were
washed in PBSX, exposed to Hoechst 33342 (Molecular
Probes), diluted in PBS for 5 min at RT, washed in PBSX,
then aqueous mounted with Vectashield (Vector Laborato-
ries Inc, Burlingame, CA). All images were captured by
digital bright-field or fluorescence microscopy at 25–100
magnification using a Zeiss Axioplan 2 Digital Microscope
with Cooke SensiCam 32 bit Camera.
Determination of viral titer
Reovirus T3 titer in brain tissue was determined by
standard plaque assay techniques on confluent monolayers
of L929 fibroblasts. Specimens were frozen (70 jC) and
thawed (RT) three times, briefly sonicated, and then diluted
into gelatinized saline. Duplicate aliquots were serially di-
K.H. Edelmann et al. / Virology 322 (2004) 231–238 237luted in 10-fold steps and samples from at least three
consecutive dilutions were inoculated onto L929 cell mono-
layers. Monolayers were stained with neutral red dye at day 6
postinfection and plaques counted. Viral titer was deter-
mined by averaging the number of plaques seen at the most
informative dilution and correcting for inoculum size and
dilution factor. Results are presented as log10 plaque forming
units (pfu)/ml F SEM.Acknowledgments
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